Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Leizian de Souza Amorim
Observed name:
Leizian S Amorim
Institution:
Universidade Federal de São Paulo
Observed institutions:
Universidade Federal da Bahia,
Universidade Federal de Sergipe,
Universidade Tiradentes,
Hospital Geral de Fortaleza,
Hospital Universitário Getúlio Vargas,
Universidade Federal de São Paulo
show all 6
ORCID:
0000-0002-6545-0163
Observed ORCID:
0000-0002-6545-0163
OpenAlex ID:
A5103996088
Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorders
2021
·
Samira Luisa Apostolos-Pereira
, Lis Campos Ferreira
, et al.
·
Neurology Neuroimmunology & Neuroinflammation
·
29
PDF
Incidence and clinical outcome of Coronavirus disease 2019 in a cohort of 11,560 Brazilian patients with multiple sclerosis
2021
·
REDONE.br – Neuroimmunology Brazilian Study Group Focused on COVID-19 and MS
, Lis Campos Ferreira
, et al.
·
Multiple Sclerosis Journal
·
29
The impact of changing diagnostic criteria on disability in a Brazilian multiple sclerosis cohort
2025
·
Felipe Toscano Lins de Menezes
, Jéssica Monique Dias Alencar
, et al.
·
Arquivos de Neuro-Psiquiatria
·
5
PDF
Active tuberculosis and multiple sclerosis: the importance of screening before treatment
2025
·
Leizian de Souza Amorim
, Paloma Peter Travassos Zaidan
, et al.
·
Arquivos de Neuro-Psiquiatria
PDF
Reduction of CD8 T lymphocytes in dimethyl fumarate-treated multiple sclerosis patients: Decreased production of IL-2.
2023
·
Breno Bandoni Ferrari
, Amanda Dias Rocha Lima
, et al.
·
BCTRIMS Annual Meeting (Brazilian Committee for Treatment and Research in Multiple Sclerosis)
Increased production of anti-inflammatory molecules by a B cell subset of Multiple Sclerosis patients treated with Natalizumab
2023
·
Breno B Ferrari
, Amanda D R Lima
, et al.
·
BCTRIMS Annual Meeting (Brazilian Committee for Treatment and Research in Multiple Sclerosis)
Show more works
View as search
Works count:
6
Citation count:
63
H-index:
3
I10-index:
2
Year
Topic
Type